Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine
Condition: Herpes Zoster Interventions: Biological: Recombinant Zoster Vaccine; Biological: Placebo; Biological: Zoster Vaccine Recombinant, Adjuvanted Sponsors: Wuhan BravoVax Co., Ltd.; Shanghai BravoBio Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Clinical Trials | Herpes | Research | Shingles (Herpes Zoster) Vaccine | Vaccines | Varicella-Zoster Virus Vaccine